Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-09-13 5:54 pm Purchase | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 555,736,060 75.200% | 379,871,779 (+216.00%) | View |
| 2023-03-13 4:51 pm Purchase | 13D | Summit Therapeutics Inc. SMMT | Zanganeh Mahkam | 36,882,393 5.270% | 31,399,111 (+572.63%) | View |
| 2023-02-16 4:01 pm Unchanged | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 175,864,281 78.100% | 0 (Unchanged) | View |
| 2023-02-14 4:03 pm Sale | 13G | Summit Therapeutics Inc. SMMT | Polar Capital Holdings Plc | 0 0.000% | -6,295,713 (Position Closed) | View |
| 2022-12-09 5:24 pm Purchase | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 175,864,281 81.800% | 9,346,434 (+5.61%) | View |
| 2022-08-18 4:43 pm Purchase | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 166,517,847 81.150% | 94,870,338 (+132.41%) | View |
| 2022-02-14 10:47 am Purchase | 13G | Summit Therapeutics Inc. SMMT | Polar Capital Holdings Plc | 6,295,713 6.400% | 495,713 (+8.55%) | View |
| 2021-05-14 4:27 pm Purchase | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 71,647,509 70.780% | 11,365,921 (+18.85%) | View |
| 2021-04-22 5:11 pm Unchanged | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 60,281,588 69.370% | 0 (Unchanged) | View |
| 2021-03-26 5:07 pm Unchanged | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 60,281,588 69.370% | 0 (Unchanged) | View |
| 2021-02-16 07:32 am Purchase | 13G | Summit Therapeutics Inc. SMMT | Polar Capital Holdings Plc | 5,800,000 7.050% | 5,800,000 (New Position) | View |
| 2020-11-25 4:11 pm Purchase | 13D | Summit Therapeutics Inc. SMMT | Zanganeh Mahkam | 5,483,282 6.580% | 3,323 (+0.06%) | View |
| 2020-11-10 4:20 pm Purchase | 13D | Summit Therapeutics Inc. SMMT | Zanganeh Mahkam | 5,479,959 6.580% | 149,701 (+2.81%) | View |
| 2020-11-10 4:11 pm Purchase | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 60,281,588 69.940% | 4,341,317 (+7.76%) | View |
| 2020-10-06 7:28 pm Purchase | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 55,940,271 69.110% | 9,730,539 (+21.06%) | View |
| 2020-09-28 4:40 pm Purchase | 13D | Summit Therapeutics Inc. SMMT | Zanganeh Mahkam | 5,330,258 7.800% | 5,330,258 (New Position) | View |
| 2020-09-28 4:37 pm Purchase | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 46,209,732 64.890% | 46,209,732 (New Position) | View |
| 2020-06-17 2:38 pm Sale | 13D | Summit Therapeutics Inc. SMMT | LANSDOWNE PARTNERS (UK) LLP | 13,664,880 4.060% | -4,006,035 (-22.67%) | View |
| 2020-05-15 10:18 am Sale | 13D | Summit Therapeutics Inc. SMMT | LANSDOWNE PARTNERS (UK) LLP | 17,670,915 5.260% | -3,472,585 (-16.42%) | View |
| 2020-03-26 2:59 pm Unchanged | 13D | Summit Therapeutics Inc. SMMT | LANSDOWNE PARTNERS (UK) LLP | 21,143,500 6.300% | 0 (Unchanged) | View |